RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang(Jinyintan Hospital), Bin Cao(Shandong Provincial Hospital), Li Guo(Shihezi University), Jingchuan Zhong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Lü(Binzhou Medical University), Dingyu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Liu(China-Japan Friendship Hospital), Zhenghui Huang(Beijing Chao-Yang Hospital, Capital Medical University), Jiuyang Xu(Tsinghua University), Dan Cui(Harbin Medical University), Guohui Fan(China-Japan Friendship Hospital), Liang Kang(Sun Yat-sen University), Decui Xu(Jinyintan Hospital), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Chen(ShanghaiTech University), Yanping Li(Sichuan University), Jianwei Wang(Zhejiang Cancer Hospital), Xia Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Caihong Li(Jinyintan Hospital), Yue Zhao(Jinyintan Hospital), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yeming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wuxiang Xie(Peking University), Lixue Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xing Zhou(Zhengzhou University), Jianfeng Luo(Chinese Academy of Medical Sciences & Peking Union Medical College), Geng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shengjin Tu(Jinyintan Hospital), Lianhan Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lili Ren(Huaibei Normal University)
Cited by 4,281
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k